住友ファーマの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2020/03/17 | 1,213 | 1,259 | 1,178 | 1,222 | -23 | -1.8% | 2,479,300 |
2020/03/16 | 1,295 | 1,335 | 1,242 | 1,245 | -22 | -1.7% | 1,668,400 |
2020/03/13 | 1,224 | 1,321 | 1,211 | 1,267 | -91 | -6.7% | 2,518,400 |
2020/03/12 | 1,408 | 1,447 | 1,356 | 1,358 | -87 | -6% | 1,870,100 |
2020/03/11 | 1,436 | 1,458 | 1,412 | 1,445 | -8 | -0.6% | 1,678,600 |
2020/03/10 | 1,412 | 1,464 | 1,385 | 1,453 | +37 | +2.6% | 2,300,800 |
2020/03/09 | 1,443 | 1,458 | 1,383 | 1,416 | -87 | -5.8% | 1,673,500 |
2020/03/06 | 1,542 | 1,550 | 1,487 | 1,503 | -59 | -3.8% | 1,511,100 |
2020/03/05 | 1,616 | 1,616 | 1,550 | 1,562 | -15 | -1% | 1,797,500 |
2020/03/04 | 1,553 | 1,592 | 1,544 | 1,577 | +5 | +0.3% | 1,355,500 |
2020/03/03 | 1,601 | 1,612 | 1,569 | 1,572 | -3 | -0.2% | 2,394,300 |
2020/03/02 | 1,537 | 1,595 | 1,535 | 1,575 | +14 | +0.9% | 2,498,800 |
2020/02/28 | 1,556 | 1,589 | 1,553 | 1,561 | -42 | -2.6% | 2,995,600 |
2020/02/27 | 1,610 | 1,616 | 1,571 | 1,603 | -31 | -1.9% | 1,832,300 |
2020/02/26 | 1,620 | 1,640 | 1,612 | 1,634 | -7 | -0.4% | 1,317,500 |
2020/02/25 | 1,630 | 1,647 | 1,604 | 1,641 | -71 | -4.1% | 1,245,700 |
2020/02/21 | 1,718 | 1,740 | 1,708 | 1,712 | -10 | -0.6% | 739,300 |
2020/02/20 | 1,740 | 1,774 | 1,720 | 1,722 | +9 | +0.5% | 1,290,400 |
2020/02/19 | 1,739 | 1,747 | 1,711 | 1,713 | -30 | -1.7% | 1,129,600 |
2020/02/18 | 1,772 | 1,781 | 1,733 | 1,743 | -35 | -2% | 629,200 |
2020/02/17 | 1,798 | 1,803 | 1,769 | 1,778 | -30 | -1.7% | 636,300 |
2020/02/14 | 1,808 | 1,819 | 1,797 | 1,808 | -11 | -0.6% | 836,800 |
2020/02/13 | 1,840 | 1,841 | 1,812 | 1,819 | -20 | -1.1% | 737,800 |
2020/02/12 | 1,892 | 1,892 | 1,828 | 1,839 | -47 | -2.5% | 1,624,700 |
2020/02/10 | 1,898 | 1,898 | 1,871 | 1,886 | -31 | -1.6% | 844,700 |
2020/02/07 | 1,908 | 1,934 | 1,897 | 1,917 | +16 | +0.8% | 926,400 |
2020/02/06 | 1,864 | 1,905 | 1,858 | 1,901 | +65 | +3.5% | 1,532,700 |
2020/02/05 | 1,821 | 1,836 | 1,801 | 1,836 | +32 | +1.8% | 1,572,500 |
2020/02/04 | 1,800 | 1,825 | 1,793 | 1,804 | -19 | -1% | 1,915,400 |
2020/02/03 | 1,878 | 1,879 | 1,814 | 1,823 | -80 | -4.2% | 1,713,500 |
2020/01/31 | 1,782 | 1,914 | 1,781 | 1,903 | -76 | -3.8% | 2,903,800 |
2020/01/30 | 1,995 | 2,015 | 1,968 | 1,979 | -16 | -0.8% | 857,600 |
2020/01/29 | 2,000 | 2,005 | 1,982 | 1,995 | -7 | -0.3% | 834,300 |
2020/01/28 | 1,993 | 2,007 | 1,980 | 2,002 | -21 | -1% | 1,145,100 |
2020/01/27 | 2,049 | 2,060 | 2,009 | 2,023 | -57 | -2.7% | 753,700 |
2020/01/24 | 2,111 | 2,114 | 2,078 | 2,080 | -29 | -1.4% | 659,500 |
2020/01/23 | 2,130 | 2,133 | 2,105 | 2,109 | -43 | -2% | 607,800 |
2020/01/22 | 2,165 | 2,170 | 2,149 | 2,152 | -15 | -0.7% | 599,500 |
2020/01/21 | 2,154 | 2,171 | 2,138 | 2,167 | +7 | +0.3% | 785,900 |
2020/01/20 | 2,153 | 2,162 | 2,144 | 2,160 | +3 | +0.1% | 405,300 |
2020/01/17 | 2,141 | 2,166 | 2,123 | 2,157 | +24 | +1.1% | 721,700 |
2020/01/16 | 2,168 | 2,181 | 2,129 | 2,133 | -3 | -0.1% | 835,400 |
2020/01/15 | 2,176 | 2,181 | 2,121 | 2,136 | -30 | -1.4% | 813,800 |
2020/01/14 | 2,180 | 2,191 | 2,155 | 2,166 | -9 | -0.4% | 687,400 |
2020/01/10 | 2,149 | 2,175 | 2,140 | 2,175 | +46 | +2.2% | 847,100 |
2020/01/09 | 2,111 | 2,139 | 2,104 | 2,129 | +59 | +2.9% | 805,700 |
2020/01/08 | 2,094 | 2,109 | 2,037 | 2,070 | -50 | -2.4% | 1,061,200 |
2020/01/07 | 2,095 | 2,123 | 2,088 | 2,120 | +30 | +1.4% | 889,000 |
2020/01/06 | 2,080 | 2,101 | 2,061 | 2,090 | -40 | -1.9% | 1,456,900 |
2019/12/30 | 2,149 | 2,155 | 2,124 | 2,130 | -26 | -1.2% | 560,600 |
1151~
1200
件表示中 / 3588件
類似銘柄と比較する
現在ご覧いただいている「住友ファーマ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
住友ファーマ | 59,400円 | +7.5% | - | 0.00% | - | 2.07倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
日本新薬 | 426,500円 | +5.9% | 0.0% | 2.91% | 9.58倍 | 1.22倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
サワイGHD | 203,000円 | +4.0% | +25.4% | 2.61% | 9.38倍 | 1.23倍 |
|
ジェネリック(後発)薬大手メーカー。21年春に沢井製薬が持株会社化。大型買収で米国本格展開 |
科研薬 | 428,700円 | +22.8% | +113.0% | 4.43% | 11.44倍 | 1.05倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の2本柱。後発品も展開 |
キッセイ薬 | 359,000円 | +14.5% | -2.3% | 2.51% | 13.13倍 | 0.70倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
市場注目の銘柄
チャート関連のコラム